Background Antibiotic resistance (ABR) is a worldwide problem and Bangladesh is a major
contributor to this owing to its poor healthcare standards, along with the misuse and overuse …

We need to apply novel findings towards sustainable approaches for treating and preventing
Shigella infections. Vaccines and alternative treatments are under development and may …

Background Diarrhoea is the leading cause of morbidity and mortality in the world
particularly in developing countries and among vulnerable groups of the population. Gram …

Shigella sonnei is the emerging pathogen globally, as it is the second common infectious
species of shigellosis (bloody diarrhoea) in low-and middle-income countries (LMICs) and …

Herein, we describe the enhanced antifungal activity of silver nanoparticles biosynthesized
by cell free filtrate of Trichoderma viride (MTCC 5661) in comparison to chemically …

Shigella spp. are some of the key pathogens responsible for the global burden of diarrhoeal
disease. These facultative intracellular bacteria belong to the family Enterobacteriaceae …

Shigellosis causes more than 200,000 deaths worldwide and most of this burden falls on
Low-and Middle-Income Countries (LMICs), with a particular incidence in children under 5 …

Shigella flexneri is the most common cause of bacterial dysentery in low-income countries.
Despite this, S. flexneri remains largely unexplored from a genomic standpoint and is still …

Shigellosis represents a major burden of disease in developing countries. A low infectious
dose allows the disease to be spread effectively. Although shigellosis is mostly a self …

Shigella flexneri is a leading etiologic agent of diarrhea in low socioeconomic countries.
Notably, various serotypes in S. flexneri are reported from different regions of the world. The …